Some intellectuals argue that experts from the pharmaceutical companies are obligated to spend money researching medicine which Will be beneficial to the people in undeveloped countries while others oppose this view, submitting that their major responsibilities is to make profit.I will delve into the two sides of the debate and conclude that the drug companies will reduce the mortality rate in the impoverished countries when they spend money investigating medicines.
Examining the latter view suggests that money is essential for the smooth running of the companies and sustenance of workers, which will be a benefit to the economy status of poorer countries. If there is enough funds the investors will be able to pay their workers and this will promotes the quality of life of most people that live in that country, also, prevents the company from becoming bankrupted. Majority of the drug company owner in Nigeria, do it for it’s profit and they have been able to increase the accessibility to money among their workers.
On the contrary, those championing the former view suggests that research is their major duty. They emphasized the relevance of research in drugs companies, counteracting the spread of infections and provision of vaccines for terminal disease and to me, these are superior to any form of profit making drugs sectors. This is because new drugs would be produced and they will put an end to life threatening diseases such as Malaria, Measles, Polio and Small pox. The medications and vaccines invented for these infections have drastically reduce the mortality rate in undeveloped countries. It is therefore incontrovertible that not only do spending on researching medicine is essential but that these surpasses any money making drug companies.
In conclusion, while there are valid supporting points for both side, I assert that drug companies should spend money researching medications to reduce mortality rate in poorer countries